Teva Pharma (NYSE: TEVA) issued the following statement regarding Stichting Preferred Shares Mylan’s (Nasdaq: MYL) decision to exercise its call ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Insider Trades Mergers and Acquisitions

Teva Pharma (TEVA) to Acquire Allergan Genetics (AGN) in $40.5B Cash and Stock DealJuly 27, 2015 6:03 AM Teva Issues StatementJuly 23, 2015 9:04 AM Teva Launches Educational Initiative to Arm Women with Facts about Emergency ContraceptionJuly 23, 2015 9:00 AM Mylan (MYL) Acknowledges Call Option Exercised by Stichting July 23, 2015 8:52 AM